Centogene is a leading company in the field of genetic diagnostics and precision medicine, dedicated to transforming clinical, genetic, and biochemical data into medical solutions for patients. Based in Rostock, Germany, the company operates globally.

Founded in 2006 with the mission of revolutionizing the diagnosis of rare diseases, Centogene has since scaled its capabilities to diagnose more than 2,500 rare diseases in over 100 countries, building one of the largest genetic databases in the world (1,000,000 individuals) while developing cutting-edge technology for the interpretation of genetic data. With over 350 scientific publications, Centogene is a key partner for physicians in rapid and accurate genetic diagnosis, and for pharmaceutical companies focused on developing treatments for orphan diseases.